Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 2.085
Filter
2.
Int J Low Extrem Wounds ; : 15347346241286216, 2024 Sep 23.
Article in English | MEDLINE | ID: mdl-39311011

ABSTRACT

Stem cell therapy in diabetic foot ulcer has emerged as a promising treatment option to promote ulcer healing. This network meta-analysis was undertaken to evaluate how they compete with each other and their ranking with respect to chances of ulcer healing. A systematic search strategy to retrieve data from five databases, were used to identify potential studies. Randomized controlled trial or clinical controlled trial, published in English, using any type of stem cells as intervention in individuals aged over 18 years diagnosed with diabetic foot ulcers were included. This network meta-analysis was performed using frequentist method using R version 4.2.1. Eighteen clinical trials were included in the study which included 13 interventions. The study found that most of the stem cells were significantly promoting ulcer healing chances with human viable wound matrix (hVWM) [RR 2.91; CI: 1.28, 6.64], peripheral blood mononuclear cells (PBMNC) [RR 2.35; CI: 1.21, 4.55], bone marrow mesenchymal stem cells (BMMSCs) [RR 2.20; CI: 1.34, 3.60], were top three stem cell options among all. P score also suggested the same. Risk of bias study suggested that there was "some concern or "high risk'' among majority of studies. It is evident from this study that bone marrow mononuclear cells were found to be most effective in wound healing in cases of diabetic foot ulcer in that order. Though there was no significant difference between these and more studies were required to ascertain whether they differ in term of efficacy for the clinical outcome of ulcer healing.

3.
Nanomedicine (Lond) ; : 1-30, 2024 Sep 23.
Article in English | MEDLINE | ID: mdl-39311508

ABSTRACT

Carbon dots (CQDs), zero-dimensional carbon nanostructures, have attracted considerable interest among researchers due to their versatile applications. CQDs exhibit exceptional photoluminescent properties and high quantum yield, making them ideal candidates for bioimaging, drug delivery and environmental sensing. Their biocompatibility and tunable surface chemistry enable targeted therapeutic delivery and real-time imaging with minimal toxicity. Additionally, CQDs are emerging as promising materials in optoelectronics, offering sustainable alternatives in light-emitting diodes and solar cells. This review underscores the unparalleled adaptability of green CQDs in bridging the gap between laboratory research and practical applications, paving the way for innovative solutions in healthcare and environmental monitoring. Through comprehensive analysis, it advances the understanding of CQDs, positioning them at the forefront of next-generation nanomaterials with significant translational impact.


[Box: see text].

4.
Colloids Surf B Biointerfaces ; 245: 114212, 2024 Sep 06.
Article in English | MEDLINE | ID: mdl-39276757

ABSTRACT

The advancement of nanotechnology and their application has intrigued a significant interest in green synthesis and application of organic and inorganic nanomaterials like graphene oxide (GO) and silver nanoparticles (AgNP). This study explores the intrinsic physiochemical properties of silver (Ag)-decorated graphene oxide (GO) nanosheets synthesized via a green approach, focusing on their photoluminescence behaviour and in vivo cellular biocompatibility with embryonic zebrafish. The nanocomposites were characterized using various spectroscopic and microscopic techniques to elucidate their structural and optical properties. Results reveal that the Ag-decorated GO nanosheets exhibit enhanced photoluminescence compared to pristine GO with an SPR at 405 nm and emission at 676 nm, attributed to the synergistic effects of Ag nanoparticles and GO. In addition, in vivo biocompatibility assessments using embryonic zebrafish demonstrate minimal cytotoxicity and high cellular viability upon exposure to the nanocomposites with an LC50 of 38 µg/ml, indicating their potential for biomedical applications. Further investigations into the interactions between the nanomaterials and biological systems provide valuable insights into their safety profile and suggest their suitability for various biomedical and therapeutic applications. Overall, this study offers a comprehensive understanding of the physiochemical characteristics and biological compatibility of Ag-decorated GO nanosheets, contributing to the advancement of nanotechnology in biomedicine and related fields.

5.
Cancers (Basel) ; 16(17)2024 Sep 02.
Article in English | MEDLINE | ID: mdl-39272919

ABSTRACT

Colorectal cancer (CRC) is a heterogeneous disease and classified into various subtypes, among which transcriptional alterations result in CRC progression, metastasis, and drug resistance. Forkhead-box M1 (FOXM1) is a proliferation-associated transcription factor which is overexpressed in CRC and the mechanisms of FOXM1 regulation have been under investigation. Previously, we showed that FOXM1 binds to promoters of certain microRNAs. Database mining led to several microRNAs that might interact with FOXM1 3'UTR. The interactions between shortlisted microRNAs and FOXM1 3'UTR were quantitated by a dual-luciferase reporter assay. MicroRNA-532-3p interacted with the 3'UTR of the FOXM1 mRNA transcript most efficiently. MicroRNA-532-3p was ectopically overexpressed in colorectal cancer (CRC) cell lines, leading to reduced transcript and protein levels of FOXM1 and cyclin B1, a direct transcriptional target of FOXM1. Further, a clonogenic assay was conducted in overexpressed miR-532-3p CRC cells that revealed a decline in the ability of cells to form colonies and a reduction in migratory and invading potential. These alterations were reinforced at molecular levels by the altered transcript and protein levels of the conventional EMT markers E-cadherin and vimentin. Overall, this study identifies the regulation of FOXM1 by microRNA-532-3p via its interaction with FOXM1 3'UTR, resulting in the suppression of proliferation, migration, and invasion, suggesting its role as a tumor suppressor in CRC.

6.
J Educ Health Promot ; 13: 184, 2024.
Article in English | MEDLINE | ID: mdl-39268430

ABSTRACT

BACKGROUND: The interaction between people and advanced information and communication technologies results in behavioral addictions, one of them is nomophobia. In a health care setting, nurses constitute a significant proportion of healthcare workers. Therefore, discovering the level of nomophobia and its impact on constructs such as mindfulness and self-efficacy is very important as this might affect the psychological and physical well-being of nurses, which can impact the quality of patient care. The study aimed to assess the level of nomophobia and its relationship with mindfulness and self-efficacy of nurses. METHODS AND MATERIAL: An analytical cross-sectional study was carried out in a tertiary care hospital. A total of 420 nurses were selected using a convenience sampling technique. Self-structured questionnaire was used to assess socio-demographic characteristics and mobile phone use. Standardized questionnaires were administered in pen and paper format for measuring nomophobia, mindfulness, and self-efficacy. Statistical Package for Social Sciences (SPSS) version 20.0 was used. Karl Pearson's correlation coefficient and Chi-square test were employed to analyze the data. RESULTS: The majority of nurses (99.5%) had nomophobia. About half of them (53.3%) had a moderate level of nomophobia. Nearly half of nurses had high level of mindfulness (52.6%) and self-efficacy (53.3%) respectively. Further, nomophobia was found to be negatively correlated with mindfulness (r = -0.289) and self-efficacy (r = -0.278). CONCLUSION: Nomophobia poses a risk to the mindfulness and self-efficacy of nurses. Continuing education should focus on awareness programs emphasizing good practices in the use of current technologies.

7.
World J Gastrointest Pharmacol Ther ; 15(5): 97570, 2024 Sep 05.
Article in English | MEDLINE | ID: mdl-39281264

ABSTRACT

Liver transplantation (LT) in patients with hepatocellular carcinoma (HCC) and chronic liver disease (CLD) is limited by factors such as tumor size, number, portal venous or hepatic venous invasion and extrahepatic disease. Although previously established criteria, such as Milan or UCSF, have been relaxed globally to accommodate more potential recipients with comparable 5-year outcomes, there is still a subset of the population that has advanced HCC with or without portal vein tumor thrombosis without detectable extrahepatic spread who do not qualify or are unable to be downstaged by conventional methods and do not qualify for liver transplantation. Immune checkpoint inhibitors (ICI) such as atezolizumab, pembrolizumab, or nivolumab have given hope to this group of patients. We completed a comprehensive literature review using PubMed, Google Scholar, reference citation analysis, and CrossRef. The search utilized keywords such as 'liver transplant', 'HCC', 'hepatocellular carcinoma', 'immune checkpoint inhibitors', 'ICI', 'atezolizumab', and 'nivolumab'. Several case reports have documented successful downstaging of HCC using the atezolizumab/bevacizumab combination prior to LT, with acceptable early outcomes comparable to other criteria. Adverse effects of ICI have also been reported during the perioperative period. In such cases, a 1.5-month interval between ICI therapy and LT has been suggested. Overall, the results of downstaging using combination immunotherapy were encouraging and promising. Early reports suggested a potential ray of hope for patients with CLD and advanced HCC, especially those with multifocal HCC or branch portal venous tumor thrombosis. However, prospective studies and further experience will reveal the optimal dosage, duration, and timing prior to LT and evaluate both short- and long-term outcomes in terms of rejection, infection, recurrence rates, and survival.

8.
J Arthroplasty ; 2024 Sep 14.
Article in English | MEDLINE | ID: mdl-39284389

ABSTRACT

BACKGROUND: Dexamethasone has been shown to alleviate pain, yet the optimal dosing and safety profiles remain unclear. This study aimed to evaluate the analgesic efficacy and impact on sleep quality of three different doses of intravenous dexamethasone in patients undergoing total knee arthroplasty (TKA). METHODS: In this randomized, triple-blind, clinical trial, we assessed the analgesic effects of three doses of intravenous dexamethasone (4 mg, 8 mg, and 16 mg) in adult patients who underwent TKA. Pain was measured using the visual analog scale (VAS) at 1, 12, 24, and 48 hours postoperatively, and sleep quality was assessed two weeks post-surgery. RESULTS: A total of 90 participants were enrolled in the study, with 30 participants in each dosing group. The mean VAS scores at 12, 24, and 48 hours postoperatively showed significant improvement from baseline in all groups. Notably, the 16 mg and 8 mg dexamethasone groups demonstrated significantly greater pain reduction compared to the 4 mg group (P < 0.05). Additionally, sleep quality significantly improved in the 16 mg and 8 mg groups (P < 0.05). CONCLUSION: Dexamethasone at doses of 4 mg, 8 mg, and 16 mg effectively reduces pain and enhances sleep quality in patients undergoing TKA, with the 16 mg dose showing the most pronounced effects at 12, 24, and 48 hours postoperatively.

9.
Adv Tech Stand Neurosurg ; 53: 79-92, 2024.
Article in English | MEDLINE | ID: mdl-39287804

ABSTRACT

OBJECTIVE: Endoscopic surgery has emerged in the recent years as an alternative to the conventional microsurgical approaches for removal of the deep-seated brain and intraventricular tumors. Endoport has enhanced the tumor access and visualization without any significant brain retraction. In this chapter, we describe the surgical technique of the endoscopic excision of the deep-seated intra-axial brain tumors using tubular retraction system with review of the literature. METHODS: The endoscopic endoport technique that we use at our institution for the surgical management of intraventricular and intraparenchymal brain tumors has been described in details with illustrations. RESULTS: Results from the literature review of brain parenchymal and intraventricular port surgery were analyzed, and the feasibility and safety of this technique were discussed. Surgical complication avoidance and management were highlighted. The port technique offers numerous potential advantages, including: (1) reducing focal brain injury by distributing retraction forces homogenously; (2) minimizing white matter disruption and the risk of fascicles injury during cannulation; (3) ensuring stability of the surgical corridor during the procedure; (4) preventing inadvertent expansion of the corticectomy and white fiber tract dissection throughout surgery; (5) protecting the surrounding tissues against iatrogenic injuries caused by instrument entry and reentry. CONCLUSION: The endoport-assisted endoscopic technique is a safe and minimally invasive method that offers an effective alternative option for resection of intraventricular and parenchymal brain lesions. Excellent outcome comparable to other surgical approaches can be achieved with acceptable complications.


Subject(s)
Brain Neoplasms , Humans , Brain Neoplasms/surgery , Brain Neoplasms/pathology , Neuroendoscopy/methods , Neuroendoscopy/instrumentation , Cerebral Ventricle Neoplasms/surgery , Cerebral Ventricle Neoplasms/pathology , Male , Female , Neurosurgical Procedures/methods , Middle Aged , Adult
10.
Sci Rep ; 14(1): 20899, 2024 Sep 08.
Article in English | MEDLINE | ID: mdl-39245750

ABSTRACT

This paper introduces a novel design for a universal DC-DC and DC-AC converter tailored for DC/AC microgrid applications using Approximate Dynamic Programming and Artificial Neural Networks (ADP-ANN). The proposed converter is engineered to operate efficiently with both low-power battery and single-phase AC supply, utilizing identical side terminals and switches for both chopper and inverter configurations. This innovation reduces component redundancy and enhances operational versatility. The converter's design emphasizes minimal switch usage while ensuring efficient conversion to meet diverse load requirements from battery or AC sources. A conceptual example illustrates the design's principles, and comprehensive analyses compare the converter's performance across various operational modes. A test bench model, rated at 3000W, demonstrates the converter's efficacy in all five operational modes with AC/DC inputs. Experimental results confirm the system's robustness and adaptability, leveraging ADP-ANN for optimal performance. The paper concludes by outlining potential applications, including microgrids, electric vehicles, and renewable energy systems, highlighting the converter's key advantages such as reduced complexity, increased efficiency, and broad applicability.

11.
PLoS One ; 19(8): e0309063, 2024.
Article in English | MEDLINE | ID: mdl-39159152

ABSTRACT

During pregnancy, two fetomaternal interfaces, the placenta-decidua basalis and the fetal membrane-decidua parietals, allow for fetal growth and maturation and fetal-maternal crosstalk, and protect the fetus from infectious and inflammatory signaling that could lead to adverse pregnancy outcomes. While the placenta has been studied extensively, the fetal membranes have been understudied, even though they play critical roles in pregnancy maintenance and the initiation of term or preterm parturition. Fetal membrane dysfunction has been associated with spontaneous preterm birth (PTB, < 37 weeks gestation) and preterm prelabor rupture of the membranes (PPROM), which is a disease of the fetal membranes. However, it is unknown how the individual layers of the fetal membrane decidual interface (the amnion epithelium [AEC], the amnion mesenchyme [AMC], the chorion [CTC], and the decidua [DEC]) contribute to these pregnancy outcomes. In this study, we used a single-cell transcriptomics approach to unravel the transcriptomics network at spatial levels to discern the contributions of each layer of the fetal membranes and the adjoining maternal decidua during the following conditions: scheduled caesarian section (term not in labor [TNIL]; n = 4), vaginal term in labor (TIL; n = 3), preterm labor with and without rupture of membranes (PPROM; n = 3; and PTB; n = 3). The data included 18,815 genes from 13 patients (including TIL, PTB, PPROM, and TNIL) expressed across the four layers. After quality control, there were 11,921 genes and 44 samples. The data were processed by two pipelines: one by hierarchical clustering the combined cases and the other to evaluate heterogeneity within the cases. Our visual analytical approach revealed spatially recognized differentially expressed genes that aligned with four gene clusters. Cluster 1 genes were present predominantly in DECs and Cluster 3 centered around CTC genes in all labor phenotypes. Cluster 2 genes were predominantly found in AECs in PPROM and PTB, while Cluster 4 contained AMC and CTC genes identified in term labor cases. We identified the top 10 differentially expressed genes and their connected pathways (kinase activation, NF-κB, inflammation, cytoskeletal remodeling, and hormone regulation) per cluster in each tissue layer. An in-depth understanding of the involvement of each system and cell layer may help provide targeted and tailored interventions to reduce the risk of PTB.


Subject(s)
Decidua , Extraembryonic Membranes , Premature Birth , Transcriptome , Female , Humans , Pregnancy , Decidua/metabolism , Extraembryonic Membranes/metabolism , Premature Birth/genetics , Fetal Membranes, Premature Rupture/genetics , Fetal Membranes, Premature Rupture/metabolism , Term Birth/genetics , Amnion/metabolism , Amnion/cytology , Adult , Chorion/metabolism , Gene Expression Profiling
12.
Poult Sci ; 103(10): 104078, 2024 Oct.
Article in English | MEDLINE | ID: mdl-39096829

ABSTRACT

In the past, we demonstrated that oligodeoxynucleotides containing CpG motifs (CpG-ODN) mimicking bacterial DNA, stimulate the innate immune system of neonatal broiler chickens and protect them against Escherichia coli and Salmonella Typhimurium (S. Typhimurium) septicemia. The first line of innate immune defense mechanism is formed by heterophils and plays a critical protective role against bacterial septicemia in avian species. Therefore, the objectives of this study were 1) to explore the kinetics of CpG-ODN mediated antibacterial mechanisms of heterophils following single or twice administration of CpG-ODN in neonatal broiler chickens and 2) to investigate the kinetics of the immunoprotective efficacy of single versus twice administration of CpG-ODN against S. Typhimurium septicemia. In this study, we successfully developed and optimized flow cytometry-based assays to measure phagocytosis, oxidative burst, and degranulation activity of heterophils. Birds that received CpG-ODN had significantly increased (p < 0.05) phagocytosis, oxidative burst, and degranulation activity of heterophils as early as 24 h following CpG-ODN administration. Twice administration of CpG-ODN significantly increased the phagocytosis activity of heterophils. In addition, our newly developed CD107a based flow cytometry assay demonstrated a significantly higher degranulation activity of heterophils following twice than single administration of CpG-ODN. However, the oxidative burst activity of heterophils was not significantly different between birds that received CpG-ODN only once or twice. Furthermore, delivery of CpG-ODN twice increased immunoprotection against S. Typhimurium septicemia compared to once but the difference was not statistically significant. In conclusion, we demonstrated enhanced bactericidal activity of heterophils after administration of CpG-ODN to neonatal broiler chickens. Further investigations will be required to identify other activated innate immune cells and the specific molecular pathways associated with the CpG-ODN mediated activation of heterophils.


Subject(s)
Chickens , Immunity, Innate , Oligodeoxyribonucleotides , Poultry Diseases , Salmonella Infections, Animal , Salmonella typhimurium , Sepsis , Animals , Chickens/immunology , Oligodeoxyribonucleotides/pharmacology , Oligodeoxyribonucleotides/administration & dosage , Salmonella typhimurium/physiology , Poultry Diseases/prevention & control , Poultry Diseases/immunology , Poultry Diseases/microbiology , Salmonella Infections, Animal/prevention & control , Salmonella Infections, Animal/immunology , Salmonella Infections, Animal/microbiology , Sepsis/veterinary , Sepsis/prevention & control , Sepsis/immunology , Immunity, Innate/drug effects , Animals, Newborn , Phagocytosis/drug effects , Respiratory Burst/drug effects
13.
Biomed Pharmacother ; 179: 117372, 2024 Oct.
Article in English | MEDLINE | ID: mdl-39208668

ABSTRACT

Polymeric nanoparticles have emerged as promising contenders for addressing the intricate challenges encountered in brain tumor therapy due to their distinctive attributes, including adjustable size, biocompatibility, and controlled drug release kinetics. This review comprehensively delves into the latest developments in synthesizing, characterizing, and applying polymeric nanoparticles explicitly tailored for brain tumor therapy. Various synthesis methodologies, such as emulsion polymerization, nanoprecipitation, and template-assisted fabrication, are scrutinized within the context of brain tumor targeting, elucidating their advantages and limitations concerning traversing the blood-brain barrier. Furthermore, strategies pertaining to surface modification and functionalization are expounded upon to augment the stability, biocompatibility, and targeting prowess of polymeric nanoparticles amidst the intricate milieu of the brain microenvironment. Characterization techniques encompassing dynamic light scattering, transmission electron microscopy, and spectroscopic methods are scrutinized to evaluate the physicochemical attributes of polymeric nanoparticles engineered for brain tumor therapy. Moreover, a comprehensive exploration of the manifold applications of polymeric nanoparticles encompassing drug delivery, gene therapy, imaging, and combination therapies for brain tumours is undertaken. Special emphasis is placed on the encapsulation of diverse therapeutics within polymeric nanoparticles, thereby shielding them from degradation and enabling precise targeting within the brain. Additionally, recent advancements in stimuli-responsive and multifunctional polymeric nanoparticles are probed for their potential in personalized medicine and theranostics tailored for brain tumours. In essence, this review furnishes an all-encompassing overview of the recent strides made in tailoring polymeric nanoparticles for brain tumor therapy, illuminating their synthesis, characterization, and multifaceted application.


Subject(s)
Brain Neoplasms , Nanoparticles , Polymers , Humans , Polymers/chemistry , Brain Neoplasms/drug therapy , Brain Neoplasms/pathology , Nanoparticles/chemistry , Animals , Blood-Brain Barrier/metabolism , Drug Delivery Systems/methods , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/chemistry
14.
Chem Asian J ; : e202400752, 2024 Aug 11.
Article in English | MEDLINE | ID: mdl-39129039

ABSTRACT

In this study, we utilized various Pr-doped CeO2 catalysts (Pr=5, 10, 20, and 30 wt.%) as a support medium for the dispersion of cobalt (Co) nanoparticles, aiming to investigate the impact of oxygen vacancies on the water-gas shift (WGS) reaction. Different characterization techniques were employed to understand the insights into the structure-activity relationship governing the performance of Pr doped ceria supported Co catalysts towards WGS reaction. Our findings reveal that Co/Pr-CeO2 catalysts at optimum Pr loading (10 wt.%) exhibit a superior CO conversion (88 %) facilitated by the presence of more oxygen vacancies induced by Pr doping into the CeO2 lattice, as opposed to the performance of the pure Co/CeO2 catalytic system. It was also found that the highest activity was obtained at increased intrinsic oxygen vacancies and strong synergy between Co and Pr/CeO2 support, fostering more favorable CO activation at the interfacial sites, thus accounting for the observed enhanced activity.

15.
Vet Res Commun ; 48(5): 3437-3443, 2024 Oct.
Article in English | MEDLINE | ID: mdl-39133398

ABSTRACT

Malignant catarrhal fever (MCF) presents a sporadic yet significant threat to livestock and wildlife. A comprehensive investigation in Karnataka, India into the prevalence and transmission patterns of sheep-associated MCF (SA-MCF) was conducted. A total of 507 sheep peripheral blood leukocyte samples from 13 districts along with 27 cows and 10 buffalo samples from various regions in Karnataka were tested for SA-MCF infection i.e. Ovine gammaherpesvirus 2 (OvHV-2) using heminested PCR. Furthermore, serum samples collected from 73 cows and 15 buffalo suspected of MCF were tested using a commercially available ELISA kit. Additionally, histopathological examinations of affected tissues and phylogenetic analysis of viral tegument protein sequences were conducted. Our findings indicated a 20.11%, 33.33% and 20% positivity for OvHV-2 in sheep, cows and buffalo respectively by PCR. Statistical analysis revealed a significant association between the age of sheep and the detection of OvHV-2. Seven cows and one buffalo serum samples tested positive for ELISA. Clinical findings in bovids were consistent with typical MCF signs, and histopathological results revealed multi-organ involvement characterised by necrotising vasculitis and lymphoid hyperplasia. The nucleotide pairwise identity matrix revealed 99.5% identity between the sequences obtained in the study with sequences from other states. The phylogenetic analysis of partial tegument protein sequences from bovid and sheep samples suggested a close genetic relationship between the local OvHV-2 strains and those from various global regions. Crucially, this study underscores the widespread presence of SA-MCF in Karnataka, with significant implications for both livestock management and wildlife conservation.


Subject(s)
Buffaloes , Gammaherpesvirinae , Malignant Catarrh , Phylogeny , Animals , Malignant Catarrh/virology , Malignant Catarrh/transmission , Malignant Catarrh/epidemiology , Malignant Catarrh/pathology , India/epidemiology , Sheep , Gammaherpesvirinae/genetics , Gammaherpesvirinae/isolation & purification , Gammaherpesvirinae/classification , Cattle , Buffaloes/virology , Sheep Diseases/virology , Sheep Diseases/transmission , Sheep Diseases/epidemiology , Sheep Diseases/pathology , Female , Prevalence , Enzyme-Linked Immunosorbent Assay/veterinary , Cattle Diseases/virology , Cattle Diseases/epidemiology , Cattle Diseases/transmission , Cattle Diseases/pathology , Polymerase Chain Reaction/veterinary
16.
Viruses ; 16(8)2024 Aug 19.
Article in English | MEDLINE | ID: mdl-39205297

ABSTRACT

Bovine adenovirus (BAdV)-3 genome encodes a 26 kDa core protein designated as protein VII, which localizes to the nucleus/nucleolus. The requirement of a protein VII-complementing cell line for the replication of VII-deleted BAdV-3 suggests that protein VII is required for the production of infectious progeny virions. An analysis of the BAV.VIId+ virus (only phenotypically positive for protein VII) detected no noticeable differences in the expression and incorporation of viral proteins in the virions. Moreover, protein VII does not appear to be essential for the formation of mature BAV.VIId+. However, protein VII appeared to be required for the efficient assembly of mature BAV.VIId- virions. An analysis of the BAV.VIId- virus (genotypically and phenotypically negative for protein VII) in non-complementing cells detected the inefficient release of virions from endosomes, which affected the expression of viral proteins or DNA replication. Moreover, the absence of protein VII altered the proteolytic cleavage of protein VI of BAV.VIId-. Our results suggest that BAdV-3 protein VII appears to be required for efficient production of mature virions. Moreover, the absence of protein VII produces non-infectious BAdV-3 by altering the release of BAdV-3 from endosomes/vesicles.


Subject(s)
Mastadenovirus , Virion , Virus Replication , Animals , Virion/metabolism , Virion/genetics , Cattle , Mastadenovirus/genetics , Mastadenovirus/physiology , Mastadenovirus/metabolism , Cell Line , Viral Proteins/metabolism , Viral Proteins/genetics , Virus Assembly , Viral Core Proteins/metabolism , Viral Core Proteins/genetics , DNA Replication
17.
Angew Chem Int Ed Engl ; : e202411472, 2024 Aug 19.
Article in English | MEDLINE | ID: mdl-39157914

ABSTRACT

Motional properties of proteins govern recognition, catalysis, and regulation. The dynamics of tightly interacting residues can form intramolecular dynamic networks, dependencies fine-tuned by evolution to optimize a plethora of functional aspects. The constructive interaction of residues from different proteins to assemble intermolecular dynamic networks is a similarly likely case but has escaped thorough experimental assessment due to interfering association/dissociation dynamics. Here, we use fast-MAS solid-state 15N R1ρ NMR relaxation dispersion aided by molecular-dynamics simulations to mechanistically assess the hierarchy of individual µs timescale motions arising from a crystal-crystal contact, in the absence of translational motion. In contrast to the monomer, where particular mutations entail isolated perturbations, specific intermolecular interactions couple the motional properties between distant residues in the same protein. The mechanistic insights obtained from this conceptual work may improve our understanding on how intramolecular allostery can be tuned by intermolecular interactions via assembly of dynamic networks from previously isolated elements.

18.
Cureus ; 16(7): e64501, 2024 Jul.
Article in English | MEDLINE | ID: mdl-39139326

ABSTRACT

Anti-Lewis antibodies are often not clinically significant since they do not react at 37°C. These antibodies have, however, occasionally been linked to hemolytic transfusion reactions (HTR). We report a case of naturally occurring anti-Lewis-a (Le-a) in a 58-year-old patient found during routine blood grouping. As Lewis antigen is a low-prevalence antigen, compatible units were found after crossmatching two units of packed red cells. Lewis blood group antigen antibodies frequently react at lower temperatures and remain clinically insignificant, but in rare cases, they may react at a higher temperature of 37°C and cause a hemolytic episode or impair the lifespan of incompatible red blood cells in the recipient. Hence, antigen-negative crossmatch compatible units should be used for transfusion. In an emergency, the donor's register, with its comprehensive phenotypic profile, can be quite helpful in supplying blood for transfusions.

19.
Sci Rep ; 14(1): 18882, 2024 08 14.
Article in English | MEDLINE | ID: mdl-39143261

ABSTRACT

Oligodeoxynucleotides containing CpG motifs (CpG-ODN) can promote antimicrobial immunity in chickens by enriching immune compartments and activating immune cells. Innate memory, or trained immunity, has been demonstrated in humans and mice, featuring the absence of specificity to the initial stimulus and subsequently cross-protection against pathogens. We hypothesize that CpG-ODN can induce trained immunity in chickens. We delivered single or multiple administrations of CpG-ODN to birds and mitochondrial oxidative phosphorylation (OXPHOS) and glycolysis of peripheral blood mononuclear cells were quantified using Seahorse XFp. Next, chickens were administered with CpG-ODN twice at 1 and 4 day of age and challenged with Escherichia coli at 27 days of age. The CpG-ODN administered groups had significantly higher mitochondrial OXPHOS until 21 days of age while cellular glycolysis gradually declined by 14 days of age. The group administered with CpG-ODN twice at 1 and 4 days of age had significantly higher survival, lower clinical score and bacterial load following challenge with E. coli at 27 d of age. This study demonstrated the induction of trained immunity in broiler chickens following administration of CpG-ODN twice during the first 4 days of age to protect birds against E. coli septicemia at 27 days of age.


Subject(s)
Chickens , Escherichia coli Infections , Escherichia coli , Oligodeoxyribonucleotides , Poultry Diseases , Sepsis , Animals , Oligodeoxyribonucleotides/administration & dosage , Oligodeoxyribonucleotides/pharmacology , Chickens/immunology , Escherichia coli Infections/immunology , Escherichia coli Infections/prevention & control , Escherichia coli Infections/veterinary , Sepsis/immunology , Sepsis/prevention & control , Poultry Diseases/prevention & control , Poultry Diseases/immunology , Poultry Diseases/microbiology , Immunity, Innate/drug effects , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/metabolism , Oxidative Phosphorylation , Trained Immunity
20.
Sci Total Environ ; 949: 175243, 2024 Nov 01.
Article in English | MEDLINE | ID: mdl-39098420

ABSTRACT

Bioaccumulation of d-Limonene in environment due to the aggrandised usage of their natural sources like citrus food wastes and industrial day to day life products has raised concern to their biotoxicity to environment biotic health. Moreover, their after-usage discharge to aquatic system has enhanced the distress of posing threat and needs attention. This study entails mechanistic and molecular evaluation of in-vivo biotoxicity of d-Limonene in zebrafish embryo models. Experimental analysis excavated the controlled concentration-dependent morphological, physiological and cellular in-vivo impact of d-Limonene in zebrafish embryos through significant changes in oxidative stress, steatosis and apoptosis regulated via 6-fold and 5-fold mRNA expression change in p53 and Sod1 genes. Computational evaluation deduced the cellular mechanism of d-limonene biotoxicity as irregularities in oxidative stress, apoptosis and steatosis due of their intrinsic interaction with metabolic proteins like Zhe1a (-4.8 Kcal/mol), Sod1(-5.3 Kcal/mol), p53, caspase3 and apoa1 leading to influential change in structural and functional integrity of the metabolic proteins. The study unravelled the measured in-vivo biotoxicity of d-Limonene at cellular and molecular level to advocate the controlled usage of d-Limonene related natural and industrial product for a sustainable environmental health.


Subject(s)
Apoptosis , Limonene , Oxidative Stress , Zebrafish , Animals , Limonene/toxicity , Apoptosis/drug effects , Water Pollutants, Chemical/toxicity , Embryo, Nonmammalian/drug effects , Fatty Liver/chemically induced
SELECTION OF CITATIONS
SEARCH DETAIL